ADA-011

· Adanate, Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ADA-011, covering 2025-01-28 to 2025-01-28. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study of ADA-011 for Subjects With Advanced Solid Tumors [Phase 1]